ArticleLung cancer (Amsterdam, Netherlands)2021

Impact of XPO1 mutations on survival outcomes in metastatic non-small cell lung cancer (NSCLC).

Misako Nagasaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.